UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

NSGO-OV-UMB1/ENGOT-OV30: A phase II study of durvalumab in combination with the anti-CD73 monoclonal antibody Oleclumab in patients with relapsed ovarian cancer

Gynecologic oncology, 2024-09, Vol.188, p.103-110

2024

Volltextzugriff (PDF)

The relationship of VEGF polymorphisms with serum VEGF levels and progression-free survival in patients with epithelial ovarian cancer

Gynecologic oncology, 2010-04, Vol.117 (1), p.109-116

2010

Volltextzugriff (PDF)

The predictive value of serum VEGF in multiresistant ovarian cancer patients treated with bevacizumab

Gynecologic oncology, 2010-08, Vol.118 (2), p.167-171

2010

Volltextzugriff (PDF)

Risk-reducing mastectomy and salpingo-oophorectomy in unaffected BRCA mutation carriers: uptake and timing

Clinical genetics, 2010-04, Vol.77 (4), p.342-349

2010

Volltextzugriff (PDF)

Prognostic impact of prechemotherapy HE4 and CA-125 levels in patients with ovarian cancer

Gynecologic oncology, 2011-03, Vol.120, p.S75-S75

2011

Volltextzugriff (PDF)

Adherence to international recommendations in the governance and organisation of Nordic cervical cancer screening programmes

Acta oncologica, 2020-11, Vol.59 (11), p.1308-1315

2020

Volltextzugriff (PDF)

4 Prognostic impact of tumor infiltrating natural killer cells in ovarian carcinoma

International journal of gynecological cancer, 2019-09, Vol.29 (Suppl 3), p.A3-A3

2019

Volltextzugriff (PDF)

59 Natural killer cells and treatment effect in recurrent ovarian cancer

International journal of gynecological cancer, 2019-09, Vol.29 (Suppl 3), p.A33-A33

2019

Volltextzugriff (PDF)

Clinical Performance of Human Papillomavirus (HPV) Testing versus Cytology for Cervical Cancer Screening: Results of a Large Danish Implementation Study

Clinical epidemiology, 2020-01, Vol.12, p.203-213

2020

Volltextzugriff (PDF)

The prognostic importance of cyclooxygenase 2 and HER2 expression in epithelial ovarian cancer

International journal of gynecological cancer, 2007-07, Vol.17 (4), p.798-807

2007

Volltextzugriff (PDF)

Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer

International journal of gynecological cancer, 2008-07, Vol.18 (4), p.702-710

2008

Volltextzugriff (PDF)

Comparison of the clinical performance of an HPV mRNA test and an HPV DNA test in triage of atypical squamous cells of undetermined significance (ASC-US)

Cytopathology (Oxford), 2012-12, Vol.23 (6), p.389-395

2012

Volltextzugriff (PDF)

The prognostic importance of cyclooxygenase 2 and HER2 expression in epithelial ovarian cancer

International journal of gynecological cancer, 2007-07, Vol.17 (4), p.798-807

2007

Volltextzugriff (PDF)

8003 Bevacizumab in heavily pre-treated ovarian cancer patients and the predictive value of serum VEGF

European journal of cancer supplements, 2009, Vol.7 (2), p.451-451

2009

Volltextzugriff (PDF)

0129: Cox2 Expression and Relation to Long Term Survival in Epithelial Ovarian Cancer

International journal of gynecological cancer, 2006-10, Vol.16 (Suppl 3), p.638-638

2006

Volltextzugriff (PDF)

Association of ERCC1 protein expression to platinum resistance in epithelial ovarian cancer

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.5530-5530

2009

Volltextzugriff (PDF)

Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-up

Human vaccines & immunotherapeutics, 2021-04, Vol.17 (4), p.943-949

2021

Volltextzugriff (PDF)

8036 POSTER The Value of the Risk of Ovarian Malignancy Algorithm (ROMA) as a Predictor of Platinum Resistance and Survival for Ovarian Cancer Patients

European journal of cancer (1990), 2011, Vol.47, p.S538-S538

2011

Volltextzugriff (PDF)

Virtual microscopy: an evaluation of its validity and diagnostic performance in routine histologic diagnosis of skin tumors

Human pathology, 2010-12, Vol.41 (12), p.1770-1776

2010

Volltextzugriff (PDF)

The Prognostic and Predictive Value of Combined HE4 and CA-125 in Ovarian Cancer Patients

International journal of gynecological cancer, 2012-11, Vol.22 (9), p.1474-1482

2012

Volltextzugriff (PDF)

Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.5568-5568

2007

Volltextzugriff (PDF)

Immunohistochemical expression of wilms tumor gene protein in different histologic subtypes of ovarian carcinomas

Archives of pathology & laboratory medicine (1976), 2005-01, Vol.129 (1), p.85-88

2005

Volltextzugriff (PDF)

Identification of high-risk patients by human epididymis protein 4 levels during follow-up of ovarian cancer

Oncology letters, 2016-06, Vol.11 (6), p.3967-3974

2016

Volltextzugriff (PDF)

Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer

International journal of gynecological cancer, 2008-07, Vol.18 (4), p.702-710

2008

Volltextzugriff (PDF)

F1-1Predictive gene expression profile of breast cancer patients treated with tamoxifen

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2008, Vol.116 (3), p.223-252

2008

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(28)
Tagungsberichte
(1)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(17)
Science & Technology
(17)
Ovarian Cancer
(13)
Humans
(12)
Female
(10)
Adult
(9)
Oncology
(9)
Aged
(8)
Middle Aged
(8)
Obstetrics & Gynecology
(7)
Tumors
(6)
Hematology, Oncology And Palliative Medicine
(5)
Ovarian Neoplasms - Genetics
(5)
Chemotherapy
(4)
Ovarian Neoplasms - Drug Therapy
(4)
Pathology
(4)
Predictive Value Of Tests
(4)
Aged, 80 And Over
(3)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Biological And Medical Sciences
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

NSGO-OV-UMB1/ENGOT-OV30: A phase II study of durvalumab in combination with the anti-CD73 monoclonal antibody Oleclumab in patients with relapsed ovarian cancer

The relationship of VEGF polymorphisms with serum VEGF levels and progression-free survival in patients with epithelial ovarian cancer

The predictive value of serum VEGF in multiresistant ovarian cancer patients treated with bevacizumab

Risk-reducing mastectomy and salpingo-oophorectomy in unaffected BRCA mutation carriers: uptake and timing

Prognostic impact of prechemotherapy HE4 and CA-125 levels in patients with ovarian cancer

Adherence to international recommendations in the governance and organisation of Nordic cervical cancer screening programmes

4 Prognostic impact of tumor infiltrating natural killer cells in ovarian carcinoma

59 Natural killer cells and treatment effect in recurrent ovarian cancer

Clinical Performance of Human Papillomavirus (HPV) Testing versus Cytology for Cervical Cancer Screening: Results of a Large Danish Implementation Study

The prognostic importance of cyclooxygenase 2 and HER2 expression in epithelial ovarian cancer

Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer

Comparison of the clinical performance of an HPV mRNA test and an HPV DNA test in triage of atypical squamous cells of undetermined significance (ASC-US)

The prognostic importance of cyclooxygenase 2 and HER2 expression in epithelial ovarian cancer

8003 Bevacizumab in heavily pre-treated ovarian cancer patients and the predictive value of serum VEGF

0129: Cox2 Expression and Relation to Long Term Survival in Epithelial Ovarian Cancer

Association of ERCC1 protein expression to platinum resistance in epithelial ovarian cancer

Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-up

8036 POSTER The Value of the Risk of Ovarian Malignancy Algorithm (ROMA) as a Predictor of Platinum Resistance and Survival for Ovarian Cancer Patients

Virtual microscopy: an evaluation of its validity and diagnostic performance in routine histologic diagnosis of skin tumors

The Prognostic and Predictive Value of Combined HE4 and CA-125 in Ovarian Cancer Patients

Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer

Immunohistochemical expression of wilms tumor gene protein in different histologic subtypes of ovarian carcinomas

Identification of high-risk patients by human epididymis protein 4 levels during follow-up of ovarian cancer

Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer

F1-1Predictive gene expression profile of breast cancer patients treated with tamoxifen

Suchergebnisse filtern